NDC 42571-243

ACETAZOLAMIDE EXTENDED-RELEASE

Acetazolamide Extended-release

ACETAZOLAMIDE EXTENDED-RELEASE is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Micro Labs Limited. The primary component is Acetazolamide.

Product ID42571-243_b0c40c55-f53a-69ea-e053-2a95a90a54db
NDC42571-243
Product TypeHuman Prescription Drug
Proprietary NameACETAZOLAMIDE EXTENDED-RELEASE
Generic NameAcetazolamide Extended-release
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2020-12-01
Marketing CategoryANDA / ANDA
Application NumberANDA207401
Labeler NameMicro Labs Limited
Substance NameACETAZOLAMIDE
Active Ingredient Strength500 mg/1
Pharm ClassesCarbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 42571-243-01

100 CAPSULE in 1 BOTTLE (42571-243-01)
Marketing Start Date2020-12-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "ACETAZOLAMIDE EXTENDED-RELEASE" or generic name "Acetazolamide Extended-release"

NDCBrand NameGeneric Name
42571-243ACETAZOLAMIDE EXTENDED-RELEASEAcetazolamide Extended-Release
50090-5608ACETAZOLAMIDE EXTENDED-RELEASEAcetazolamide Extended-Release
50268-042ACETAZOLAMIDE EXTENDED-RELEASEAcetazolamide Extended-Release
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.